Octreotide depot formulation with constantly high exposure...

Details Octreotide depot formulation with constantly high exposure... Octreotide depot formulation with constantly high exposure...

A - Human Necessities

61

K

A61K 47/34 (2006.01) A61K 9/00 (2006.01) A61K 9/14 (2006.01) A61K 9/16 (2006.01) A61K 38/31 (2006.01)

Patent

CA 2746968

The present invention relates to sustained release formulations comprising as active ingredient octreotide or a pharmaceutically-acceptable salt thereof and two different linear polylactide-co-glycolide polymers (PLGAs).

La présente invention porte sur des formulations à libération entretenue comprenant en tant qu'ingrédient actif de l'octréotide ou un sel pharmaceutiquement acceptable de celle-ci et deux polymères polylactide-co-glycolide linéaires différents (PLGA).

Affiliated with

Also associated with

Rating

Octreotide depot formulation with constantly high exposure... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Octreotide depot formulation with constantly high exposure..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Octreotide depot formulation with constantly high exposure... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1854598